Transport of proteolytic enzymes across Caco-2 cell monolayers

被引:32
作者
Bock, U
Kolac, C
Borchard, G
Koch, K
Fuchs, R
Streichhan, P
Lehr, CM
机构
[1] Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-66123 Saarbrucken, Germany
[2] Mucos Pharma GmbH, Geretsried, Germany
关键词
absorption; proteases; trypsin; chymotrypsin; bromelain; papain; tight junctions;
D O I
10.1023/A:1011949521144
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To investigate the mechanisms by which proteolytic enzymes, such as trypsin, chymotrypsin, papain, and bromelain, are able to cross the intestinal mucosal barrier after oral administration to man. Methods. Filter-grown Caco-2 cell monolayers were incubated with proteolytic enzymes and then the transepithelial electrical resistance (TEER) and the transport of the paracellular marker fluorescein were monitored. The effects of the enzymes on the cells were investigated by light microscopy and by biochemical assays. Transport of intact proteases across the cells was verified by monitoring the proteolytic activity and MALDI-TOF mass spectroscopic identification of undegraded trypsin. Results. Depending on time, concentration, and side of exposure to Caco-2 cell monolayers, all proteases decreased the TEER and increased the transport of fluorescein. Some morphological and metabolic changes were observed. The effects were reversible, but until 24 hours after removal of the proteases. Under the conditions of this in-vitro model, approximately 10% of the apically applied dose reached the basolateral compartment as biologically active, non-degraded molecules. Conclusions. Proteolytic enzymes were found to exert considerable effects on the barrier function of Caco-2 monolayers, facilitating the transport of normally non-absorbable compounds. This suggests the also reported, but so far unexplained, systemic absorption of proteolytic enzymes after oral administration in vivo may occur by self-enhanced paracellular transport.
引用
收藏
页码:1393 / 1400
页数:8
相关论文
共 33 条
[1]  
AMBRUS JL, 1967, CLIN PHARMACOL THER, V8, P362
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .7. EFFECTS OF PHARMACEUTICAL SURFACTANT EXCIPIENTS AND BILE-ACIDS ON TRANSEPITHELIAL PERMEABILITY IN MONOLAYERS OF HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ANDERBERG, EK ;
NYSTROM, C ;
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (09) :879-887
[4]   SODIUM CAPRATE ELICITS DILATATIONS IN HUMAN INTESTINAL TIGHT JUNCTIONS AND ENHANCES DRUG ABSORPTION BY THE PARACELLULAR ROUTE [J].
ANDERBERG, EK ;
LINDMARK, T ;
ARTURSSON, P .
PHARMACEUTICAL RESEARCH, 1993, 10 (06) :857-864
[5]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .2. EFFECT OF EXTRACELLULAR CALCIUM-CONCENTRATION ON THE PARACELLULAR TRANSPORT OF DRUGS OF DIFFERENT LIPOPHILICITIES ACROSS MONOLAYERS OF INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
MAGNUSSON, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (07) :595-600
[6]  
AVAKIAN S, 1964, CLIN PHARMACOL THER, V5, P712
[7]  
BORGES EL, 1995, BRAZ J MED BIOL RES, V28, P65
[8]   Intestinal absorption of undegraded proteins in men: Presence of bromelain in plasma after oral intake [J].
Castell, JV ;
Friedrich, G ;
Kuhn, CS ;
Poppe, GE .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 273 (01) :G139-G146
[9]  
CASTELL JV, 1995, ABSORPTION ORALLY AD, P47
[10]   FORMATION OF TIGHT JUNCTIONS IN EPITHELIAL-CELLS .1. INDUCTION BY PROTEASES IN A HUMAN-COLON CARCINOMA CELL-LINE [J].
COHEN, E ;
TALMON, A ;
FAFF, O ;
BACHER, A ;
BENSHAUL, Y .
EXPERIMENTAL CELL RESEARCH, 1985, 156 (01) :103-116